Jason believes that the purchasing power of money has dropped 80% throughout his lifetime, and his diminished trust in conventional banks inspired him to develop Glint. With the recent inflationary report at 7.5%, GOLD continues to be a hedge against deflated currency values. Jason Cozens, CEO at Glint Pay, joins New to The Street giving TV Anchor Jane King his interview about the Company's fundamental ongoings.
Seth sees Tonix Pharmaceutical as an innovator in the fight against Covid and other diseases.Ī re-airing, live from the NASDAQ Market, Mr. location in Frederick, Maryland, a known biotech /biodefense sector area in the US, the facility and its personnel allow ongoing clinical trials and scientific development programs with economies of scale operational efficiencies and effectiveness. Seth talks about the Company's upcoming clinical trials on its treatment for "Long Covid." With its new 40,000+ sq. TNX-3500 is an investigational new drug not yet approved for use. Tests combining TNX-3500 and remdesivir show a robust protective solution. Another in development therapy, the Company's TNX-3500, an oral antiviral pharmaceutical, clinically shows about 65 times more potency than remdesivir in inhibiting Covid. TNXP's live vaccine, TNX-1800, in development, offers long-term protection beyond the currently used mRNA vaccines. Seth gives a comparison and talks about the limitations of each available Covid-19 treatment. Currently, in the market, there are three (3) types of treatments in the fight against Covid-19: mRNA vaccines, antiviral therapies, and monoclonal antibodies. Lederman gives the New to The Street TV audience an update about Tonix Pharmaceuticals, Inc.'s Covid-19 vaccine, antiviral pharmaceutical, and "Long" Covid-19 novel treatments and products. Seth Lederman, MD's interview with TV Anchor Jane King. New to The Street TV again re-airs the CEO at Tonix Pharmaceuticals, Inc. Division) "SPECIAL SEGMENT – Weekly Hack" interview, internet privacy expert Mr. Cryptocurrency - Pink Panda Holdings, Inc.'s PINKPANDA/USD ($PINKPANDA) interviews, Adam Carlton, Founder and CEO, and James Duchenne, CEO, Loot NFT.ĩ). Cryptocurrency – Stater's STR/USD ($STR) interview, Mr. Cryptocurrency – Faith Tribe, Ltd.'s FTRB/USD ($FTRB) interview, Mr. GlobeX Data, Ltd.'s SWISF SWIS GDT interview, Mr. Charity – Gary Sinise Foundation's interview, Mr. Tonix Pharmaceuticals, Inc.'s TNXP interview, Dr.
0 kommentar(er)
